InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

ARTIVION, INC.

AORT Clue Score41
United States Fiscal year ends December CIK 0000784199 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

52
Insider
Date
Role
Action
Shares
Price
Amount
Andrew M Green
11 Jun 2026
SVP, Regulatory and Quality
Sold after exercise
30,000
$20.69
$620.82K
Andrew M Green
11 Jun 2026
SVP, Regulatory and Quality
Sold after exercise
14,001
$20.71
$289.92K
James P Mackin
3 Dec 2025
President & CEO
Sold after exercise
30,921
$45.46
$1.41M
James P Mackin
2 Dec 2025
President & CEO
Sold after exercise
30,921
$45.56
$1.41M
Marshall S. Stanton
21 Nov 2025
SVP, Clinical & MD Affair
Sold after exercise
8,370
$45.35
$379.54K
Marshall S. Stanton
21 Nov 2025
SVP, Clinical & MD Affair
Sold after exercise
18,705
$44.91
$840.04K
Marshall S. Stanton
21 Nov 2025
SVP, Clinical & MD Affair
Sold after exercise
5,715
$45.35
$259.15K
Marshall S. Stanton
21 Nov 2025
SVP, Clinical & MD Affair
Sold after exercise
14,586
$44.92
$655.19K
Marshall S. Stanton
20 Nov 2025
SVP, Clinical & MD Affair
Sold after exercise
1,355
$44.28
$60.00K
Marshall S. Stanton
20 Nov 2025
SVP, Clinical & MD Affair
Sold after exercise
2,033
$44.32
$90.09K
Marshall S. Stanton
20 Nov 2025
SVP, Clinical & MD Affair
Sold after exercise
11,888
$44.14
$524.74K
John E Davis
17 Nov 2025
Chief Commercial Officer
Sold after exercise
6,394
$45.17
$288.82K
Jean F Holloway
17 Nov 2025
SVP, General Counsel
Sold after exercise
6,394
$45.17
$288.82K
John E Davis
14 Nov 2025
Chief Commercial Officer
Sold after exercise
6,393
$44.67
$285.58K
Jean F Holloway
14 Nov 2025
SVP, General Counsel
Sold after exercise
6,393
$45.00
$287.69K
Jean F Holloway
11 Nov 2025
SVP, General Counsel
Sold after exercise
10,000
$46.18
$461.80K
Marshall S. Stanton
27 Aug 2025
SVP, Clinical & MD Affair
Sold after exercise
18,200
$44.02
$801.22K
Jean F Holloway
25 Aug 2025
SVP, General Counsel
Sold after exercise
10,000
$44.37
$443.70K
John E Davis
12 Aug 2025
Chief Commercial Officer
Sold after exercise
10,802
$43.67
$471.76K
Jean F Holloway
12 Aug 2025
SVP, General Counsel
Sold after exercise
6,381
$43.02
$274.50K
Jean F Holloway
12 Aug 2025
SVP, General Counsel
Sold after exercise
16,975
$43.01
$730.11K
Amy Horton
8 Aug 2025
VP, Chief Accounting Officer
Sold after exercise
7,992
$38.49
$307.61K
John E Davis
11 Mar 2025
Chief Commercial Officer
Sold after exercise
15,100
$23.61
$356.55K
Jean F Holloway
11 Mar 2025
SVP, General Counsel
Sold after exercise
18,020
$23.61
$425.51K
James P Mackin
6 Mar 2025
President & CEO
Sold after exercise
70,700
$24.76
$1.75M
James P Mackin
6 Mar 2025
President & CEO
Sold after exercise
17,739
$24.80
$440.01K
Amy Horton
1 Oct 2024
VP, Chief Accounting Officer
Sold after exercise
12,430
$26.18
$325.41K
James P Mackin
20 Feb 2024
President & CEO
Sold after exercise
2,756
$18.87
$51.99K
James P Mackin
20 Feb 2024
President & CEO
Sold after exercise
10,088
$18.87
$190.31K
James P Mackin
20 Feb 2024
President & CEO
Sold after exercise
59,225
$18.85
$1.12M
John E Davis
2 Jan 2024
Senior VP, Global Sales
Sold after exercise
13,562
$18.00
$244.12K
Jean F Holloway
2 Jan 2024
SVP, General Counsel
Sold after exercise
21,229
$18.00
$382.12K
Amy Horton
15 Dec 2023
VP, Chief Accounting Officer
Sold after exercise
14,397
$19.00
$273.54K
Amy Horton
17 Feb 2023
VP, Chief Accounting Officer
Sold after exercise
3,000
$14.13
$42.39K
Amy Horton
17 Feb 2023
VP, Chief Accounting Officer
Sold after exercise
15,000
$14.08
$211.16K
James P Mackin
14 Feb 2023
President & CEO
Sold after exercise
56,500
$13.22
$747.21K
David Ashley Lee
14 Feb 2023
Executive VP, COO & CFO
Sold after exercise
31,900
$13.22
$421.87K
James P Mackin
10 Feb 2022
President & CEO
Sold after exercise
10,639
$17.86
$190.00K
James P Mackin
9 Feb 2022
President & CEO
Sold after exercise
10,638
$18.14
$192.99K
James P Mackin
8 Feb 2022
President & CEO
Sold after exercise
10,638
$17.75
$188.77K
James P Mackin
7 Feb 2022
President & CEO
Sold after exercise
10,638
$17.30
$184.05K
John E Davis
25 May 2021
Senior VP, Global Sales
Sold after exercise
6,457
$29.65
$191.47K
John E Davis
25 May 2021
Senior VP, Global Sales
Sold after exercise
880
$29.70
$26.14K
John E Davis
25 May 2021
Senior VP, Global Sales
Sold after exercise
5,402
$29.67
$160.27K
Jean F Holloway
6 May 2021
SVP, General Counsel
Sold after exercise
6,618
$30.50
$201.85K
Amy Horton
6 May 2021
VP, Chief Accounting Officer
Sold after exercise
5,731
$30.00
$171.93K
Jean F Holloway
5 May 2021
SVP, General Counsel
Sold after exercise
6,618
$29.50
$195.23K
Amy Horton
5 May 2021
VP, Chief Accounting Officer
Sold after exercise
5,186
$30.00
$155.58K
David Ashley Lee
5 May 2021
Executive VP, COO & CFO
Sold after exercise
27,242
$30.00
$817.26K
Amy Horton
30 Apr 2021
VP, Chief Accounting Officer
Sold after exercise
2,700
$30.00
$81.00K
David Ashley Lee
30 Apr 2021
Executive VP, COO & CFO
Sold after exercise
6,800
$30.00
$204.00K
James P Mackin
30 Apr 2021
President & CEO
Sold after exercise
29,469
$28.00
$825.13K
Showing 250 of 344 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 600
Amendments (4/A) skipped 29
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 9
Sales straight out of an exercise 92
Sales at will 228
Transactions with no price 0
Shares from compensation/vesting 5,261,952
Sales filed before the plan box existed 86
History held since 12 Oct 2006